Literature DB >> 33525646

New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution.

Maxence Frétaud1, Delphyne Descamps1, Daphné Laubreton1,2, Marie-Anne Rameix-Welti3,4, Jean-François Eléouët1, Thibaut Larcher5, Marie Galloux1, Christelle Langevin1,6.   

Abstract

BACKGROUND: Respiratory Syncytial Virus (RSV) is the major cause of severe acute respiratory tract illness in young children worldwide and a main pathogen for the elderly and immune-compromised people. In the absence of vaccines or effective treatments, a better characterization of the pathogenesis of RSV infection is required. To date, the pathophysiology of the disease and its diagnosis has mostly relied on chest X-ray and genome detection in nasopharyngeal swabs. The development of new imaging approaches is instrumental to further the description of RSV spread, virus-host interactions and related acute respiratory disease, at the level of the entire lung.
METHODS: By combining tissue clearing, 3D microscopy and image processing, we developed a novel visualization tool of RSV infection in undissected mouse lungs.
RESULTS: Whole tissue analysis allowed the identification of infected cell subtypes, based on both morphological traits and position within the cellular network. Furthermore, 3D imaging was also valuable to detect the cytoplasmic viral factories, also called inclusion bodies, a hallmark of RSV infection.
CONCLUSIONS: Whole lung clearing and 3D deep imaging represents an unprecedented visualization method of infected lungs to allow insight into RSV pathophysiology and improve the 2D histology analyses.

Entities:  

Keywords:  3D imaging of lungs; RSV infection; RSV tropism; inclusion bodies; tissue clearing; viral pathophysiology

Mesh:

Year:  2021        PMID: 33525646      PMCID: PMC7912480          DOI: 10.3390/v13020201

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  55 in total

1.  Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions.

Authors:  L Kolesnikova; E Mühlberger; E Ryabchikova; S Becker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.

Authors:  Aaron W Lifland; Jeenah Jung; Eric Alonas; Chiara Zurla; James E Crowe; Philip J Santangelo
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Application and assessment of optical clearing methods for imaging of tissue-engineered neural stem cell spheres.

Authors:  Molly E Boutin; Diane Hoffman-Kim
Journal:  Tissue Eng Part C Methods       Date:  2014-09-19       Impact factor: 3.056

4.  Mapping of Brain Activity by Automated Volume Analysis of Immediate Early Genes.

Authors:  Nicolas Renier; Eliza L Adams; Christoph Kirst; Zhuhao Wu; Ricardo Azevedo; Johannes Kohl; Anita E Autry; Lolahon Kadiri; Kannan Umadevi Venkataraju; Yu Zhou; Victoria X Wang; Cheuk Y Tang; Olav Olsen; Catherine Dulac; Pavel Osten; Marc Tessier-Lavigne
Journal:  Cell       Date:  2016-05-26       Impact factor: 41.582

5.  Respiratory syncytial virus tropism for olfactory sensory neurons in mice.

Authors:  Bertrand Bryche; Maxence Frétaud; Audrey Saint-Albin Deliot; Marie Galloux; Laura Sedano; Christelle Langevin; Delphyne Descamps; Marie-Anne Rameix-Welti; Jean-François Eléouët; Ronan Le Goffic; Nicolas Meunier
Journal:  J Neurochem       Date:  2020-01-08       Impact factor: 5.372

6.  Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain.

Authors:  Nathalie Castagné; Alexandra Barbier; Julie Bernard; Human Rezaei; Jean-Claude Huet; Céline Henry; Bruno Da Costa; Jean-François Eléouët
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

7.  Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

Authors:  Xavier Roux; Catherine Dubuquoy; Guillaume Durand; Thi-Lan Tran-Tolla; Nathalie Castagné; Julie Bernard; Agnès Petit-Camurdan; Jean-François Eléouët; Sabine Riffault
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

Review 8.  Animal models of respiratory syncytial virus infection.

Authors:  Geraldine Taylor
Journal:  Vaccine       Date:  2016-11-29       Impact factor: 3.641

9.  3D virtual pathohistology of lung tissue from Covid-19 patients based on phase contrast X-ray tomography.

Authors:  Marina Eckermann; Jasper Frohn; Marius Reichardt; Markus Osterhoff; Michael Sprung; Fabian Westermeier; Alexandar Tzankov; Christopher Werlein; Mark Kühnel; Danny Jonigk; Tim Salditt
Journal:  Elife       Date:  2020-08-20       Impact factor: 8.140

10.  Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro.

Authors:  Marie Galloux; Jennifer Risso-Ballester; Charles-Adrien Richard; Jenna Fix; Marie-Anne Rameix-Welti; Jean-François Eléouët
Journal:  mBio       Date:  2020-09-22       Impact factor: 7.867

View more
  1 in total

1.  Application of Advanced Imaging to the Study of Virus-Host Interactions.

Authors:  Cristina Risco
Journal:  Viruses       Date:  2021-09-29       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.